SE433171B - Framstellning av ett terapeutiskt preparat for behandling av njursjukdomar, som leder till uremi - Google Patents

Framstellning av ett terapeutiskt preparat for behandling av njursjukdomar, som leder till uremi

Info

Publication number
SE433171B
SE433171B SE7309692A SE7309692A SE433171B SE 433171 B SE433171 B SE 433171B SE 7309692 A SE7309692 A SE 7309692A SE 7309692 A SE7309692 A SE 7309692A SE 433171 B SE433171 B SE 433171B
Authority
SE
Sweden
Prior art keywords
preparation
uremi
lead
treatment
therapeutic
Prior art date
Application number
SE7309692A
Other languages
English (en)
Swedish (sv)
Other versions
SE7309692L (OSRAM
Inventor
Mackenzie Walser
Original Assignee
Mackenzie Walser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mackenzie Walser filed Critical Mackenzie Walser
Publication of SE7309692L publication Critical patent/SE7309692L/sv
Publication of SE433171B publication Critical patent/SE433171B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SE7309692A 1972-07-13 1973-07-10 Framstellning av ett terapeutiskt preparat for behandling av njursjukdomar, som leder till uremi SE433171B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27098672A 1972-07-12 1972-07-12

Publications (2)

Publication Number Publication Date
SE7309692L SE7309692L (OSRAM) 1973-07-14
SE433171B true SE433171B (sv) 1984-05-14

Family

ID=23033709

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7309692A SE433171B (sv) 1972-07-13 1973-07-10 Framstellning av ett terapeutiskt preparat for behandling av njursjukdomar, som leder till uremi

Country Status (1)

Country Link
SE (1) SE433171B (OSRAM)

Also Published As

Publication number Publication date
SE7309692L (OSRAM) 1973-07-14

Similar Documents

Publication Publication Date Title
SE409707B (sv) Forfarande for framstellning av sulfoxider, vilka er antagonister mot vissa verkningar av histamin
IT996831B (it) Procedimento per la fabbricazione dei tarpeti
SE402709B (sv) Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav
SE382751B (sv) Forfarande for framstellning av ett i beroende av tiden frigorbart farmaceutiskt preparat
NO145240C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme o-substituerte 7beta-acylamino-3-cefem-3-ol-4-karboksylsyre-forbindelser
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
IT999559B (it) Procedimento per la fabbricazione del gesso
RO68286A (ro) Procedeu pentru prepararea dihidratului acidului (d-alfa-amino-1,4-ciclohexadien-1-ilacetamido)dezacetoxicefalosporanic
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
IT1052065B (it) Sandalo per esercitazione fisica del piede
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
SE433171B (sv) Framstellning av ett terapeutiskt preparat for behandling av njursjukdomar, som leder till uremi
FI52735C (fi) Menetelmä uusien pregnadieeni-21-happojohdannaisten valmistamiseksi.
IT1013393B (it) Procedimento per la fabbricazione di microinterruttori
FI55836C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma 4-amino-3-benzylidenhydrazino-1,2,4-triazoler
NO137900C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, basisk substituerte teofyllin-derivater
IT1063143B (it) Procedimento per la preparazione del d,l pantolattone
FI812698A7 (fi) Menetelmä fungisidisten 2-asyyliamino- bentsimidatsolijohdannaisten valmistamiseksi.
SE405723B (sv) Forfarande for framstellning av ren xylitol genom fraktionerad kristallisation ur en vattenlosning av hydrerad xylos
NL157802B (nl) Werkwijze voor de bereiding van een therapeutisch preparaat voor de behandeling van gastrointestinale ziekten.
SE403110B (sv) Analogiforfarande for framstellning av diaryl-pyridyl-imidazolyl-metaner, vilka anvendes for behandling av mykoser
NO782754L (no) Analogifremgangsmaate for fremstilling av 15alfa,16alfa-methylen-4-oestren-17beta-olen
NO140980C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive isoksazolforbindelser